H30.123
Disseminated chorioretinal inflammation, peripheral, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Disseminated chorioretinal inflammation, peripheral, bilateral, is a condition that affects both eyes, involving widespread inflammation of the choroid and retina. This inflammation can impact vision and eye health, requiring proper diagnosis and management. Recognizing the signs and understanding potential causes are important steps toward seeking appropriate medical attention.
Causes & Symptoms
Clinical Causes: Autoimmune diseases, such as sarcoidosis or Behçet's disease, which cause the immune system to attack eye tissues. Infections, including tuberculosis, syphilis, toxoplasmosis, or viral infections like herpes simplex or cytomegalovirus. Inflammatory disorders related to systemic conditions affecting the blood vessels or immune response. Idiopathic origins, where no specific cause can be identified despite thorough investigation. Previous eye injuries or surgeries, leading to secondary inflammation. Use of certain medications that may trigger adverse inflammatory reactions.
Key Symptoms: Blurred or decreased vision in one or both eyes. Floaters, perceivable as spots or threads drifting in the visual field. Eye redness and sensitivity to light (photophobia). Eye pain or discomfort, which may worsen with movement. Peripheral vision changes or loss in advanced cases. Sudden vision loss or significant visual disturbances in some cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an ophthalmologist, including dilated fundus examination to observe the extent of inflammation. Diagnostic tests may include optical coherence tomography (OCT), fluorescein angiography, and laboratory tests to identify infectious or autoimmune causes. A medical history review is crucial to understand underlying systemic conditions.
Treatment Protocols: Corticosteroids, administered orally, intravenously, or via eye drops, to suppress inflammation. Immunosuppressive drugs in cases related to autoimmune conditions. Antimicrobial therapies if an infectious etiology is identified. Monitoring and follow-up examinations to assess treatment response and prevent complications. Managing systemic conditions that may contribute to ocular inflammation.
Clinical Advice & FAQs
Billing Guidance
Is H30.123 a billable ICD-10 code?
Yes, H30.123 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H30.123?
Clinical documentation must specify the nature of Disseminated chorioretinal inflammation, peripheral, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference